Faeth Therapeutics Announces FDA Grant of Fast Track Designation for PIKTOR Plus Paclitaxel in Biomarker-Selected Advanced Endometrial Cancer | FTH Stock NewsStockTitan·1 day ago, 10:30 PMFTH+0.70%
Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments | FTH Stock NewsStockTitan·Aug 13 at 10:30 PMFTH+0.70%
Faeth Therapeutics grants new-hire stock options for 11,000 shares at $25.5 eachPUBT·Aug 7 at 03:00 PMFTH+0.70%
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | FTH Stock NewsStockTitan·Aug 7 at 07:00 AMFTH+0.70%
Faeth Therapeutics to Present PK/PD Modeling That Informed PIKTOR Dose Selection in Ongoing FTH-PIK-201 Trial at Upcoming Scientific Conference | FTH Stock NewsStockTitan·Aug 6 at 10:30 PMFTH+0.70%
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga_article·Aug 3 at 07:06 AMGLMD+9.12%AMIX-3.59%
This Faeth Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Fridaybenzinga_article·Jul 31 at 08:12 AMFTH+0.70%DUOT+12.74%
Faeth Therapeutics files initial beneficial ownership statement for Khosla Ventures VI, L.PPUBT·Jul 28 at 03:15 PMFTH+0.70%
This Crowdstrike Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesdaybenzinga_article·Jul 28 at 08:02 AMHRB+1.62%FTH+0.70%
